Help Spread the Word About Vaccination During Pregnancy
Thank you for helping to spread the word about vaccines recommended during pregnancy. Right-click and download images to upload onto Instagram, Facebook, or Twitter. Use the suggested post text for captions. Where possible, e.g., Instagram Stories and Facebook Stories, please add www.HRPinfo.org as the URL to the post. Videos and animated graphics can be downloaded as .mov files as indicated.
Suggested post:
The four vaccines recommended during pregnancy— flu, Tdap, COVID-19, and RSV— greatly lower the risk of illness for both you and your baby. Talk to your doctor or midwife about when to get vaccinated during pregnancy.
Learn more at www.HRPinfo.org #VaccinesWork
Suggested post:
DYK that you can protect your baby from pertussis (whooping cough) BEFORE birth?
Getting the Tdap vaccine between 27 and 36 weeks of pregnancy helps protect newborns from this serious illness in their first months of life.
Learn more at www.HRPinfo.org #VaccinesWork
Suggested post:
Want to protect your baby against severe illness and hospitalization due to RSV?
Getting vaccinated during weeks 32 through 36 of pregnancy OR your baby receiving immunization at birth up to age 8 months can help reduce these risks.
Talk to your healthcare provider today!
Learn more at www.HRPinfo.org #VaccinesWork
Instagram and Facebook landscape posts
.jpg){kind=link}
Suggested post:
Learn more at www.hrpinfo.org #VaccinesWork
References
COVID vaccine:
Halasa NB, Olson SM, Staat MA, et al. Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(7):264-270. Published 2022 Feb 18. doi:10.15585/mmwr.mm7107e3
Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy. Am J Obstet Gynecol MFM. 2022;4(1):100492. doi:10.1016/j.ajogmf.2021.100492’
Flu shot:
Centers for Disease Control and Prevention (CDC). 3 Facts about Flu Vaccination, Treatment and Pregnancy. https://www.cdc.gov/vaccines/pregnancy/hcp-toolkit/flu-vaccine-pregnancy.html#:~:text=Getting%20a%20flu%20shot%20can,too%20young%20to%20get%20vaccinated. Accessed June 5, 2023.
CDC. Flu Vaccine Safety and Pregnancy. https://www.cdc.gov/flu/highrisk/qa_vacpregnant.htm. Accessed June 5, 2023.
Tdap:
CDC. 5 Facts about Tdap and Pregnancy. https://www.cdc.gov/vaccines/pregnancy/hcp-toolkit/tdap-vaccine-pregnancy.html. Accessed June 5, 2023.
CDC. Get a Whooping Cough Vaccine During Each Pregnancy. https://www.cdc.gov/pertussis/pregnant/mom/get-vaccinated.html. Accessed June 5, 2023.
CDC. Getting Tdap during pregnancy passes protection to baby. https://www.cdc.gov/pertussis/pregnant/mom/get-vaccinated.html#:~:text=Getting%20Tdap%20between%2027%20through,along%20with%20getting%20whooping%20cough Accessed June 5, 2023.
Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Dietz V. Vaccination Coverage Among Children Aged 19–35 Months — United States, 2015. MMWR Morb Mortal Wkly Rep 2016;65:1065–1071. DOI: http://dx.doi.org/10.15585/mmwr.mm6539a4external icon.
Murphy TV, Slade BA, Broder KR, et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Morb Mortal Wkly Rep. 2008 Jul 4;57(26):723]. MMWR Recomm Rep. 2008;57(RR-4):1-51.
RSV:
Centers for Disease Control. RSV Surveillance & Research. Accessed 09/19/2023. https://www.cdc.gov/rsv/research/index.html
Kampmann B, Madhi SA, Munjal I, et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. Apr 20 2023;388(16):1451-1464. doi:10.1056/NEJMoa2216480.
McLaughlin JM, Khan F, Schmitt HJ, et al. Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis. J Infect Dis. Mar 15 2022;225(6):1100-1111.
Simoes EAF, Madhi SA, Muller WJ, et al. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials. Lancet Child Adolesc Health. Mar 2023;7(3):180-189. doi:10.1016/S2352-4642(22)00321-2.
This resource was supported by the American College of Obstetricians and Gynecologists (ACOG) and the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as a part of a financial assistance award totaling $15,000 with 100 percent funded by ACOG and CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by ACOG, CDC/HHS, or the U.S. Government.
Last update: November 1, 2023